Metraipolis › archive › dc_4acdb43a6876
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and… — Europe PMC PMID:40855285
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40855285
- DOI
- 10.1186/s12885-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T09:00:39.713Z
- SHA-256 of the archived text
166a3f66921deda43c2c5711725900798568a81bdf1b516f89da638fe80e7041- Stable URL of this page
https://metraipolis.com/documento/dc_4acdb43a6876
How to cite
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and… — Europe PMC PMID:40855285 — Europe PMC (en), https://europepmc.org/article/MED/40855285 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4acdb43a6876 (Metraipolis archive dc_4acdb43a6876, sha256 166a3f66921deda43c2c5711725900798568a81bdf1b516f89da638fe80e7041)
BibTeX
@misc{dc4acdb43a6876,
title = {The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and… — Europe PMC PMID:40855285},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40855285},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4acdb43a6876; sha256 166a3f66921deda43c2c5711725900798568a81bdf1b516f89da638fe80e7041},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40855285. Agents can read the archived copy with the MCP tool read_document.